| X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union |
Globe Newswire |
04/29 |
07:00 |
| Capital Power reports first quarter 2026 results, underpinned by strong flexible generation performance and continued contracting success |
Globe Newswire |
04/29 |
07:00 |
| Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD |
Globe Newswire |
04/29 |
07:00 |
| First Northwest Bancorp Reports First Quarter 2026 Financial Results |
Globe Newswire |
04/29 |
07:00 |
| The Vita Coco Company Reports Strong First Quarter 2026 Financial Results and Raises Full Year Guidance |
Globe Newswire |
04/29 |
07:00 |
| Ten-League International Holdings Limited Announces 1-for-10 Reverse Share Split Effective May 1, 2026 |
Globe Newswire |
04/29 |
07:00 |
| OTC Markets Group Inc. Announces Resignation of Jason Paltrowitz, EVP Corporate Services |
Globe Newswire |
04/29 |
07:00 |
| OTC Markets Group Welcomes K2 Gold Corp to OTCQX |
Globe Newswire |
04/29 |
07:00 |
| Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium at Johns Hopkins University |
Globe Newswire |
04/29 |
07:00 |
| EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome |
Globe Newswire |
04/29 |
07:00 |
| OTC Markets Group Welcomes Cerro de Pasco Resources Inc to OTCQX |
Globe Newswire |
04/29 |
07:00 |
| Kandi Technologies Releases CEO Letter to Shareholders |
Globe Newswire |
04/29 |
07:00 |
| Brookfield Infrastructure Reports Strong First Quarter 2026 Results |
Globe Newswire |
04/29 |
06:59 |
| YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs |
Globe Newswire |
04/29 |
06:55 |
| Kite Realty Group Reports First Quarter 2026 Operating Results |
Globe Newswire |
04/29 |
06:50 |
| Virtu Announces First Quarter 2026 Results |
Globe Newswire |
04/29 |
06:50 |
| $CWH Fraud: Camping World Inventory Management Issues Trigger Securities Class Action – Investors Alerted to Contact BFA Law |
Globe Newswire |
04/29 |
06:46 |
| $MEDP Fraud: Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law |
Globe Newswire |
04/29 |
06:36 |
| Yimutian Inc. Announces Plan to Implement Change in American Depositary Shares (ADS) to Ordinary Share Ratio |
Globe Newswire |
04/29 |
06:33 |
| Regeneron Reports First Quarter 2026 Financial and Operating Results |
Globe Newswire |
04/29 |
06:30 |
| Quarterly Activities and Cashflow Report - March 2026 |
Globe Newswire |
04/29 |
06:30 |
| Parsons Reports First Quarter 2026 Results |
Globe Newswire |
04/29 |
06:30 |
| Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy |
Globe Newswire |
04/29 |
06:30 |
| Agios Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
04/29 |
06:30 |
| Costamare Inc. Reports Results For The First Quarter Ended March 31, 2026 |
Globe Newswire |
04/29 |
06:29 |
